These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19030500)

  • 21. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.
    Zanarini MC; Vujanovic AA; Parachini EA; Boulanger JL; Frankenburg FR; Hennen J
    J Pers Disord; 2003 Jun; 17(3):233-42. PubMed ID: 12839102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnosis of borderline personality disorder: problematic but better than the alternatives.
    Paris J
    Ann Clin Psychiatry; 2005; 17(1):41-6. PubMed ID: 15941030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Italian version of the Reflective Functioning Questionnaire: Validity data for adults and its association with severity of borderline personality disorder.
    Morandotti N; Brondino N; Merelli A; Boldrini A; De Vidovich GZ; Ricciardo S; Abbiati V; Ambrosi P; Caverzasi E; Fonagy P; Luyten P
    PLoS One; 2018; 13(11):e0206433. PubMed ID: 30383803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convergence between DSM-5 Section II and Section III diagnostic criteria for borderline personality disorder.
    Sellbom M; Sansone RA; Songer DA; Anderson JL
    Aust N Z J Psychiatry; 2014 Apr; 48(4):325-32. PubMed ID: 24253360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and impairment in women with Borderline Personality Disorder (BPD) with Posttraumatic Stress Disorder (PTSD), BPD without PTSD, and other personality disorders with PTSD.
    Zlotnick C; Johnson DM; Yen S; Battle CL; Sanislow CA; Skodol AE; Grilo CM; McGlashan TH; Gunderson JG; Bender DS; Zanarini MC; Shea MT
    J Nerv Ment Dis; 2003 Nov; 191(11):706-13. PubMed ID: 14614337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comorbidity of borderline personality disorder and other DSM-III-R axis II personality disorders.
    Nurnberg HG; Raskin M; Levine PE; Pollack S; Siegel O; Prince R
    Am J Psychiatry; 1991 Oct; 148(10):1371-7. PubMed ID: 1897619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mental health service utilization among borderline personality disorder patients inpatient].
    Cailhol L; Thalamas C; Garrido C; Birmes P; Lapeyre-Mestre M
    Encephale; 2015 Apr; 41(2):115-22. PubMed ID: 25526809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for borderline personality disorder in outpatient youth.
    Chanen AM; Jovev M; Djaja D; McDougall E; Yuen HP; Rawlings D; Jackson HJ
    J Pers Disord; 2008 Aug; 22(4):353-64. PubMed ID: 18684049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of borderline personality disorder in China: current status and future directions.
    Zhong J; Leung F
    Curr Psychiatry Rep; 2009 Feb; 11(1):69-73. PubMed ID: 19187712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axis II comorbidity of borderline personality disorder in adolescents.
    Loas G; Pham-Scottez A; Cailhol L; Perez-Diaz F; Corcos M; Speranza M
    Psychopathology; 2013; 46(3):172-5. PubMed ID: 23006475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity.
    Links PS; Heslegrave R; van Reekum R
    Can J Psychiatry; 1998 Apr; 43(3):265-70. PubMed ID: 9561315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Development of the Informant Five-Factor Borderline Inventory.
    Min J; Mullins-Sweatt SN; Widiger TA
    Assessment; 2021 Jul; 28(5):1334-1344. PubMed ID: 32948115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organization of co-occurring Axis II features in borderline personality disorder.
    Critchfield KL; Clarkin JF; Levy KN; Kernberg OF
    Br J Clin Psychol; 2008 Jun; 47(Pt 2):185-200. PubMed ID: 17845740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fact or fiction: diagnosing borderline personality disorder in adolescents.
    Miller AL; Muehlenkamp JJ; Jacobson CM
    Clin Psychol Rev; 2008 Jul; 28(6):969-81. PubMed ID: 18358579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
    Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
    J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hallucinations and borderline personality disorder: a review].
    Gras A; Amad A; Thomas P; Jardri R
    Encephale; 2014 Dec; 40(6):431-8. PubMed ID: 25063345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construct validity of the five factor borderline inventory.
    DeShong HL; Lengel GJ; Sauer-Zavala SE; O'Meara M; Mullins-Sweatt SN
    Assessment; 2015 Jun; 22(3):319-31. PubMed ID: 25155158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of the factors associated with the course of borderline personality disorder symptoms in adolescence.
    Skabeikyte G; Barkauskiene R
    Borderline Personal Disord Emot Dysregul; 2021 Apr; 8(1):12. PubMed ID: 33866976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotic symptoms in adolescents with borderline personality disorder features.
    Thompson KN; Cavelti M; Chanen AM
    Eur Child Adolesc Psychiatry; 2019 Jul; 28(7):985-992. PubMed ID: 30511234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elaborating on the construct validity of the Minnesota Borderline Personality Disorder Scale (MBPD): a multi-sample, longitudinal examination.
    Rojas EC; Hicks BM; Stark S; Hopwood CJ; Bornovalova MA
    Psychol Assess; 2015 Mar; 27(1):332-9. PubMed ID: 25558963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.